Additional information
| Active substance | Valproate |
|---|---|
| Hepatotoxicity | Significant risk, requires monitoring |
| Lab Test | Liver function tests, plasma levels for therapeutic monitoring |
| Strength | 200mg |
| Also known as | Valproate, VPA |
| Blood pressure | Generally has no direct effect on blood pressure |
| Trade name | Depakote, Depakene, Stavzor |
| Storage conditions | Store at room temperature, protected from light and moisture |
| Chemical name | 2-propylpentanoic acid |
| Formula | C8H16O2 |
| Substance class | Fatty acid derivative |
| Main action | Anticonvulsant and mood-stabilizing |
| Half-life | 9 to 16 hours |
| Dosage (medical) | 10–60 mg/kg/day in divided doses |
| Dosage (sports) | Not applicable |
| Effects | Reduces the frequency of seizures, stabilizes mood in bipolar disorder |
| Side effects | Nausea, vomiting, dizziness, hair loss, weight gain, tremor, liver toxicity |
| Use in sports | None |
| Manufacturer | Sanofi Aventis |
| Packing | 10 tabs/blister |
Reviews
There are no reviews yet.